Hwa Young Song Selected Research

SP-8356

4/2020	A Novel CD147 Inhibitor, SP-8356, Attenuates Pathological Fibrosis in Alkali-Burned Rat Cornea.
12/2019	SP-8356, a Novel Inhibitor of CD147-Cyclophilin A Interactions, Reduces Plaque Progression and Stabilizes Vulnerable Plaques in apoE-Deficient Mice.
1/2019	A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hwa Young Song Research Topics

Disease

4	Ischemia 01/2022 - 11/2010
3	Stroke (Strokes) 01/2022 - 06/2016
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2013
3	Infarction (Infarctions) 06/2016 - 11/2010
2	Brain Injuries (Brain Injury) 01/2022 - 11/2010
2	Ischemic Stroke 01/2022 - 06/2016
2	Brain Ischemia (Cerebral Ischemia) 01/2022 - 12/2013
2	Atherosclerosis 12/2019 - 01/2019
1	Cerebral Infarction 01/2022
1	Cerebral Hemorrhage 01/2022
1	Edema (Dropsy) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020
1	Corneal Opacity 04/2020
1	Fibrosis (Cirrhosis) 04/2020
1	Corneal Injuries 04/2020
1	Rupture 12/2019
1	Myocardial Infarction 12/2019
1	Atherosclerotic Plaque (Atheroma) 12/2019
1	Dyspepsia (Indigestion) 11/2019
1	Asthma (Bronchial Asthma) 11/2019
1	Neuralgia (Stump Neuralgia) 11/2019
1	Cough 11/2019
1	Hyperplasia 01/2019
1	Vascular Remodeling 01/2019
1	Vascular Diseases (Vascular Disease) 11/2015
1	Parkinson Disease (Parkinson's Disease) 12/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 09/2013
1	Ganglion Cysts (Ganglion) 05/2012
1	Hepatitis B 03/2012
1	Inflammation (Inflammations) 04/2011
1	Hypoxia (Hypoxemia) 11/2010
1	Left Ventricular Dysfunction 02/2010

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	SP-8356IBA 04/2020 - 01/2019
3	LipidsIBA 12/2019 - 02/2010
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2012
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2010
2	LipopolysaccharidesIBA 09/2020 - 11/2015
2	Immunoglobulins (Immunoglobulin)IBA 04/2020 - 01/2019
2	CalpainIBA 01/2020 - 12/2013
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	QuinazolinesIBA 01/2022
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	otaplimastatIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	LimoninsIBA 09/2020
1	CytokinesIBA 09/2020
1	AlkaliesIBA 04/2020
1	verbenoneIBA 04/2020
1	Cyclophilin AIBA 12/2019
1	Apolipoproteins E (ApoE)IBA 12/2019
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2019
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2019
1	Vitamin D FDA LinkGeneric 01/2019
1	WIB801CIBA 06/2016
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2015
1	Simvastatin (Zocor)FDA LinkGeneric 11/2015
1	calpeptinIBA 12/2013
1	Peptide Hydrolases (Proteases)FDA Link 12/2013
1	N-Methylaspartate (NMDA)IBA 09/2013
1	SmokeIBA 03/2012
1	Anti-Idiotypic AntibodiesIBA 03/2012
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 11/2010
1	Annexin A5IBA 11/2010
1	ChloridesIBA 11/2010
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2010
1	Propidium (Propidium Iodide)IBA 11/2010
1	Fluorescent Dyes (Fluorescent Probes)IBA 11/2010
1	Cytochromes c (Cytochrome c)IBA 11/2010
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2010
1	Insulin (Novolin)FDA Link 02/2010

Therapy/Procedure

1	Treatment Delay 01/2022
1	Traditional Medicine (Folk Remedies) 11/2019
1	Stents 01/2019
1	Ligation 01/2019
1	Therapeutics 06/2016